Article content material
NEW YORK — EDETEK Inc., a worldwide supplier of main AI-driven scientific growth platforms and companies, has engaged Capgemini to assist its ongoing developments in digital transformation inside the life sciences trade. This engagement combines EDETEK’s deep area experience and established platforms and companies with Capgemini’s superior AI and engineering capabilities, to allow EDETEK to ship modern options aimed toward optimizing scientific growth, enhancing operational effectivity, and accelerating the time-to-market for brand spanking new therapies.
Article content material
Article content material
A shared imaginative and prescient for the way forward for scientific R&D
Article content material
Article content material
Article content material
By integrating superior digital and knowledge capabilities—together with generative AI—throughout all phases of scientific trials, the venture will assist new efficiencies for pharmaceutical corporations, together with:
Article content material
- Dramatically scale back time-to-market for brand spanking new therapies.
- Enablement of self-learning, insight-driven trials for sooner, extra proactive decision-making.
- Streamlined knowledge administration and trial workflows, enhancing effectivity and precision.
- Important value reductions and boosted drug pipeline worth.
Article content material
“Working with Capgemini signifies our persevering with efforts to broaden our international capabilities in direction of delivering more practical and sooner scientific growth,”
Article content material
mentioned Dr. Shakthi Kumar, Chief Technique & Enterprise Officer at EDETEK.
Article content material
“By bringing collectively our AI-driven platforms with Capgemini’s main capabilities in life science and know-how, we are going to empower life science organizations to conduct smarter, sooner, and extra predictive scientific trials—finally enhancing affected person outcomes at scale.”
Article content material
Bringing innovation to scientific growth at scale
Article content material
The engagement combines EDETEK’s confirmed know-how with Capgemini’s international community and deep area data to scale AI-powered scientific innovation throughout the pharmaceutical trade. Collectively, it will assist make clever, agile, and data-driven scientific trials accessible to extra life sciences organizations worldwide. As well as, Capgemini will leverage its sturdy engineering capabilities to assist scale EDETEK’s platforms globally and allow continued management in reliability, innovation, and efficiency.
Article content material
“Our deep experience in next-gen scientific growth methodologies and superior AI will broaden EDETEK’s R&D cloud and eClinical platform, serving to its purchasers to unlock new ranges of agility, perception, and effectivity,”
Article content material
mentioned Thorsten Rall, International Trade Head, Life Sciences at Capgemini.
Article content material
“Collectively, we’re dedicated to redefining what’s attainable for the trade—delivering measurable worth, accelerating innovation, and shaping the way forward for healthcare by smarter, extra predictive scientific trials.”
Article content material
About EDETEK, Inc.
Article content material
Based in 2009, EDETEK delivers high-quality AI-powered platforms and scientific companies to over 100 biopharma purchasers worldwide. With a presence throughout 4 continents, EDETEK is redefining the way forward for scientific growth by clever know-how.
Article content material
Article content material
For extra details about EDETEK, please go to www.edetek.comAbout Capgemini Capgemini is a worldwide enterprise and know-how transformation associate, serving to organizations to speed up their twin transition to a digital and sustainable world, whereas creating tangible influence for enterprises and society. It’s a accountable and various group of 340,000 crew members in additional than 50 international locations. With its robust over 55-year heritage, Capgemini is trusted by its purchasers to unlock the worth of know-how to handle the whole breadth of their enterprise wants. It delivers end-to-end companies and options leveraging strengths from technique and design to engineering, all fueled by its market main capabilities in AI, generative AI, cloud and knowledge, mixed with its deep trade experience and associate ecosystem. The Group reported 2024 international revenues of €22.1 billion.
Article content material
Get The Future You Need | www.capgemini.com
Article content material
Article content material
Article content material
View supply model on businesswire.com:
Article content material
Article content material

Article content material
Article content material
Capgemini press contact:
Article content material
Article content material
Julia Zimmerman
Article content material
Article content material
Tel.:+1 847-922-7951
Article content material
Article content material
Article content material
EDETEK press contact:
Article content material
Article content material
Wei Kong
Article content material
Article content material
Tel.: +1 609-720-0888
Article content material
Article content material
Article content material
Article content material